Session Details
[P01]Poster 1 (1. Viruses / Odd number)
Wed. Sep 18, 2024 11:40 AM - 12:40 PM JST
Wed. Sep 18, 2024 2:40 AM - 3:40 AM UTC
Wed. Sep 18, 2024 2:40 AM - 3:40 AM UTC
Lecture Hall(South Hall Foyer)
[P001]Analysis Of The Functional Role Of TIMM29 In The Hepatitis B Virus Lifecycle
○Limia Abueldahab1, Masami Wada1, Shihoko Kimura1, Chiharu Morita1, Yadarat Suwanmanee1,2, Nelly Muriungi1,3, Eriko Ohsaki1,4, Keiji Ueda1 (1. Division of Virology, Department of Microbiology and Immunology, The University of Osaka, Graduate School of Medicine (Japan), 2. Division of Biological Science, Faculty of Science, Prince of Songkla University, Hatyai, Thailand. (Thailand), 3. College of Medicine and Veterinary Medicine, The University of Edinburgh, United Kingdom. (UK), 4. Center for Infectious Disease Education and Research (CiDER), Osaka University (Japan))
[P003]The Ocurence of waterborne disease outbreak in Iganga-general hospital, A cohort study
○Moses Waiswa1, Richard Talemwa2, Joyce Henderl3, carlo Nakalame4, Dennis Lubwama5 (1. Amani Children's Clinic (Uganda), 2. Uganda Development and Health Associates (Uganda), 3. Uganda Virus Research Institute (Uganda), 4. Iganga General Hospital (Uganda), 5. Makerere University- Department of Public Health (Uganda))
[P005]Inhibitory Effects of Plant-Derived Compounds on Rotavirus Pathogenesis.
○Redeemer Gyimah Asamoah1 (1. Noguchi Memorial Institute for Medical Research, Legon, Accra (Ghana))
[P007]Genome replication mechanism of a highly pathogenic emerging paramyxovirus: Sosuga virus
Lipi Akter1, Noriko Saito1, Shoichi Ashida1, Yusuke Masuda1, ○Yusuke Matsumoto1 (1. Transboundary Animal Diseases Research Center, Joint Faculty of Veterinary Medicine, Kagoshima University (Japan))
[P009]Redefinition of HSV-1 uracil-DNA glycosylase as a critical factor that allows evasion from intrinsic antiviral immunity mediated by APOBEC1 in the CNS
○Akihisa Kato1, Hayato Harima1, Kousuke Takeshima1, Yuhei Maruzuru1, Naoto Koyanagi1, Takashi Okada2, Masamichi Muramatsu3, Yasushi Kawaguchi1 (1. Division of Molecular Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo (Japan), 2. Division of Molecular and Medical Genetics, Center for Gene and Cell Therapy, The Institute of Medical Science, The University of Tokyo (Japan), 3. Department of Infectious Disease Research, Institute of Biomedical research and Innovation, Foundation for Biomedical Research and Innovation at Kobe (FBRI) (Japan))
[P011]Impact of the Interaction between Herpes Simplex Virus 1 ICP22 and FACT on Viral Gene Expression and Pathogenesis
○Shaocong Liu1, Yuhei Maruzuru1, Kosuke Takeshima1, Naoto Koyanagi1, Akihisa Kato1, Yasushi Kawaguchi1 (1. Division of Molecular Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo (Japan))
[P013]Characteristics of Torque Teno Virus Infection among Hospitalized Pediatric Acute Respiratory Infection Cases in Japan
○Princess Martey1,2, Hirono Otomaru1, Yoshifumi Fukuda3, Shingo Keita3,4, Soichiro Kawata1,3,4, Saki Tanaka1,3, Kunio Hashimoto4, Tomoyuki Hazuwa4, Michiko Toizumi1,2, Hiroyuki Moriuchi2,4, Kazuhisa Nakashima3, Lay-Myint Yoshida1,2 (1. Nagasaki University, Institute of Tropical Medicine, Department of Pediatric Infectious Diseases (Japan), 2. Nagasaki University, Graduate School of Tropical Medicine and Global Health (TMGH) (Japan), 3. Nagasaki Harbor Medical Center, Department of Pediatrics (Japan), 4. Nagasaki University Hospital, Department of Pediatrics (Japan))
[P015]Role of the Integrity of Us3 Phospho-regulation in Viral Pathogenesis
○Saori Shio1, Akihisa Kato1, Kosuke Takeshima1, Yuhei Maruzuru1, Naoto Koyanagi1, Hayato Harima2, Yasushi Kawaguchi1 (1. Division of Molecular Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan (Japan), 2. Veterinary Public Health Laboratory, Tokyo University of Agriculture and Technology, Tokyo, Japan (Japan))
[P017]Identification of the complete genome sequence of canary-associated kolmiovirus reveals its unique virological features among kolmioviruses
○Mai Kishimoto1,2, Sakiho Imai1, Masayuki Horie1,2 (1. Graduate School of Veterinary Science, Osaka Metropolitan University (Japan), 2. Osaka international Research Center for Infectious Diseases, Osaka Metropolitan University (Japan))
[P019]Analysis of novel host factors promoting cell-to-cell fusion by measles virus
○Yuma Sato1, Shura Yarimizu1, Takao Hashiguchi1 (1. Lab. of Medical Virology, Institute for Life and Medical Sciences, Kyoto University (Japan))
[P021]Detection and characterization of novel parvoviruses using public RNA sequencing data
○Jacob Anderson Cajuigan Sanchez1, Mai Kishimoto1,2, Masayuki Horie1,2 (1. Laboratory of Veterinary Microbiology, Graduate School of Veterinary Medicine, Osaka Metropolitan University (Japan), 2. Osaka International Research Center for Infectious Diseases (Japan))
[P023]Establishment of a novel mouse infection model of hepatitis B virus
○Fumihiko Takeuchi1, Sotaro Ikeda1, Yuta Tsukamoto4, Kazumi Koba1, Yutaro Shirasaka1, Yuichi Akahori2, Kazuaki Chayama3, Andrea Ablasser5,4, Hiroki Kato4, Raul Andino6, Takashi Fujita1,4 (1. Institute for Life and Medical Sciences, Kyoto University (Japan), 2. Joint Research Center for Human Retrovirus Infection, Kagoshima University (Japan), 3. Graduate School of Biomedical and Health Sciences, Hiroshima University (Japan), 4. Institute of Cardiovascular Immunology, University of Bonn (Germany), 5. École Polytechnique Fédérale de Lausanne (Switzerland), 6. University of California San Francisco (United States of America))
[P025/S04-5]Role of ANP32A in Borna disease virus replication and host specificity
○Hiromichi Matsugo1,2, Kosuke Yusa3, Akiko Makino1,2, Keizo Tomonaga1,2,4 (1. Laboratory of RNA Viruses, Department of Virus Research, Institute for Life and Medical Sciences, Kyoto University (Japan), 2. Department of Mammalian Regulatory Network, Graduate School of Biostudies, Kyoto University (Japan), 3. Laboratory of Stem Cell Genetics, Department of Biosystems Science, Institute for Life and Medical Sciences, Kyoto University (Japan), 4. Department of Molecular Virology, Graduate School of Medicine, Kyoto University (Japan))
[P027]The continued culture of SARS-CoV-2 in the presence of frontline Antiviral drugs
○Amanda Claire Horton1, Matthew Wand1, Helen Berryman1, Yasmin Surani1, Steve Pullan1, Hassan Hartman1, Rai Broadway1, Julia Tree1, J.Mark Sutton1 (1. UK Health Security Agency (UK))
[P029]A new mouse model for respiratory syncytial virus infection
○Tatsuki Takahashi1, Shiori Ueno1,2, Yoshiro Sugiura1, Sodbayasgalan Amarbayasgalan1, Enkhjin Dorjsuren1, Kenta Shimizu1, Wataru Kamitani1 (1. Department of Infectious Diseases and Host Defense, Graduate School of Medicine, Gunma University (Japan), 2. Department of Pathology, National Institute of Infectious Diseases (Japan))
[P031]Structure analysis of in silico-designed SARS-CoV-2 antibody based on UT28K.
○Liuan Chen1, Shunsuke Kita1, Tatsuhiko Ozawa2,3, Yoshiki Ikeda4, Yuki Anraku1, Jiei Sasaki2, Takao Hashiguchi2, Katsumi Maenaka1 (1. Facul. Pharm. Sci., Hokkaido Univ. (Japan), 2. LiMe, Kyoto Univ. (Japan), 3. Center for Advanced Antibody Drug Development, Univ. of Toyama (Japan), 4. iCeMS, Kyoto Univ. (Japan))
[P033]Role of cytidine acetylation in nuclear-replicating RNA viruses
○MAN LIU1, Da Teng1, Tomoyuki Honda1 (1. Okayama University (Japan))
[P035]Borna disease virus 1 employs the back-priming strategy to regulate viral RNA synthesis efficiency during infection
○Takehiro Kanda1, Keizo Tomonaga1 (1. Kyoto University (Japan))
[P037]T25 amino acid mutation in SARS-CoV-2 nsp5 reduces the symptoms of pneumonia in infected mice
○Yoshiro Sugiura1, Shiori Ueno1,2, Tatsuki Takahashi1, Kenta Shimizu1, Sodbayasgalan Amarbayasgalan1, Enkhjin Dorjsuren1, Wataru Kamitani1 (1. Department of Infectious Diseases and Host Defense, Graduate School of Medicine, Gunma University (Japan), 2. Department of Pathology, National Institute of Infectious Diseases (Japan))
[P039]The identification of escape mutant of MERS-CoV spike protein against neutralizing antibody using human-cultured cells
○Jiei Sasaki1, Satoshi Ikegame2, Hiroyuki Yoshitomi3, Hideki Ueno3, Takao Hashiguchi1 (1. LAB. OF MEDICAL VIROLOGY, Institute for Life and Medical Sciences, Kyoto University (Japan), 2. Dept of Respiratory Medicine, Grad Sch of Medical Sciences, Kyushu Univ (Japan), 3. Dept of Immunology, Grad Sch of Med, kyoto univ (Japan))
[P041]Analysis of the impact of rotavirus VP4 and VP7 genotypes on neutralizing antibody susceptibility
○Tomohiro Kotaki1, Yuta Kanai1, Megumi Onishi1, Kristen Ogden2, Kumthip Kattareeya3,4, Khamrin Pattara3,4, Shohei Minami1, Zelin Chen1, Katsuhisa Hirai1, Maneekarn Niwat3,4, Hiroto Mizushima5, Hiroshi Ushijima6, Takeshi Kobayashi1,7,8 (1. Department of Virology, Research Institute for Microbial Diseases, Osaka University (Japan), 2. Department of Pediatrics, Vanderbilt University Medical Center (United States of America), 3. Department of Microbiology, Faculty of Medicine, Chiang Mai University, Chiang Mai (Thailand), 4. Center of Excellence in Emerging and Re-emerging Diarrheal Viruses, Chiang Mai University, Chiang Mai (Thailand), 5. Thailand-Japan Research Collaboration Center on Emerging and Re-emerging Infections, Research Institute for Microbial Diseases, Osaka University (Japan), 6. Department of Pathology and Microbiology, Nihon University School of Medicine (Japan), 7. Center for Infectious Disease Education and Research, Osaka University (Japan), 8. Center for Advanced Modalities and DDS, Osaka University (Japan))
[P043]Potential of attenuated rotavirus by codon-pair deoptimization as a vaccine.
○Zelin Chen1, Tomohiro Kotaki1, Takahiro Kawagishi1, Katsuhisa Hirai1, Shohei Minami1, Yuta Kanai1, Takeshi Kobayashi1,2,3 (1. Department of Virology, Research Institue for Microbial Diseases, Osaka University (Japan), 2. Center for Infectious Disease Education and Research, Osaka University (Japan), 3. Center for Advanced Modalities and DDS, Osaka University, Osaka University (Japan))
[P045]The involvement of the host Hsp70 chaperone network in the SFTSV-mediated transcriptional regulation
○Shuhei Taguwa1,2,3, Jin Zecheng1,3, Juan Vicente Bou1,2, Junki Hirano1,2, Kentaro Uemura1,2, Kazuma Okada1,2, Chikako Ono1,2, Yoshiharu Matsuura1,2,3 (1. CiDER (Japan), 2. RIMD (Japan), 3. CAMaD, Osaka Univ. (Japan))
[P047]High agreement between in-house SYBR green-based real-time PCR targeting the RdRP gene and a commercial TaqMan probe-based for the detection of SARS-CoV-2 from clinical samples
○Muhareva Raekiansyah Raekiansyah1, Ratika Rahmasari2, Mya Myat Ngwe Tun1,3,4, Kouichi Morita1,3,5 (1. Department of Tropical Viral Vaccine Development, Institute of Tropical Medicine, Nagasaki University (Japan), 2. Microbiology and Biotechnology Laboratory, Faculty of Pharmacy, Universitas Indonesia, Depok, West Java (Indonesia), 3. Department of Virology, Institute of Tropical Medicine, Nagasaki University, Nagasaki (Japan), 4. Center for Vaccines and Therapeutic Antibodies for Emerging Infectious Diseases, Shimane University, Izumo (Japan), 5. DEJIMA Infectious Disease Research Alliance, Nagasaki University, Nagasaki (Japan))
[P049]Isolation and Characterization of SARS-CoV-2 in Kenya
○Robinson Mugasiali Irekwa1, Albina Makio1, Matthew Mutinda Munyao1, Caroline Wangui Njoroge1, Peter Kipkemboi Rotich1, Tonny Teya Nyandwaro1, Joanne Jepkemei Yego1, Anne Wanjiru Mwangi1, James Hungo Kimotho1, Ronald Tanui2, Vincent Rutto1, Samson Muuo Nzou1 (1. Kenya Medical Research Institute (Kenya), 2. Rhodes University (South Africa))